MedTrace Logo

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

NCT02782455 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-12-26

No results posted yet for this study

Summary

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Conditions

Interventions

DRUG

Flavonoids

Daflon is administered

DRUG

CDobi

Calcium dobesylate is administered

Sponsors & Collaborators

  • Services Hospital, Lahore

    lead OTHER_GOV

Principal Investigators

  • Dr. Waris Farooka, MBBS, FCPS, FRCS, FACS · Services Institute of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782455 on ClinicalTrials.gov